MYC dosage compensation is mediated by miRNA-transcription factor interactions in aneuploid cancer.
Acon M, Geiss C, Torres-Calvo J, Bravo-Estupinan D, Oviedo G, Arias-Arias JL, Rojas-Matey LA, Edwin B, Vasquez-Vargas G, Oses-Vargas Y, Guevara-Coto J, Segura-Castillo A, Siles-Canales F, Quiros-Barrantes S, Regnier-Vigouroux A, Mendes P, Mora-Rodriguez R
iScience. 2021 Nov 8;24(12):103407. doi: 10.1016/j.isci.2021.103407. eCollection 2021 Dec 17.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 176892 | pSBbi-moxGFP-P2A-T2A-cMyc-Puro | Sleeping Beauty transposon-based vector for mammalian polycistronic expression of moxGFP, c-Myc and an additional gene of interest |
| 176893 | pSBbi-moxGFP-P2A-T2A-Puro | Sleeping Beauty transposon-based vector for mammalian polycistronic expression of moxGFP and two additional genes of interest |